Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment Response

The introduction of sofosbuvir, a direct acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). Phase 3 clinical trials have demonstrated the efficacy, simplicity, and tolerability of sofosbuvir-based regimens and report high rates of sustained virological response (S...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hawaii J Med Public Health
Egile Nagusiak: Wu, Christina J, Roytman, Marina M, Hong, Leena K, Huddleston, Leslie, Trujillo, Ruby, Cheung, Alvin, Poerzgen, Peter, Tsai, Naoky CS
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: University Clinical, Education & Research Associate (UCERA) 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582387/
https://ncbi.nlm.nih.gov/pubmed/26793407
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak